Question 1

What is the catalog number for Anti-ST3GAL4 antibody?

Accepted Answer

The catalog number for Anti-ST3GAL4 antibody is PAab08265.

Question 2

What sizes are available for Anti-ST3GAL4 antibody?

Accepted Answer

Anti-ST3GAL4 antibody is available in the following size(s): 100 µg.

Question 3

Is Anti-ST3GAL4 antibody in stock?

Accepted Answer

Anti-ST3GAL4 antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Do you ship this product with dry ice?

Accepted Answer

Some products, including certain cell lines and biologics, require dry ice for transportation, which carries an additional fee shown clearly in your quotation. Dry ice delivery isn’t always possible to every destination due to transit time or local restrictions, so we check feasibility in advance and you must store the goods at the correct temperature the moment they arrive.

Question 5

Is this product species cross-reactive?

Accepted Answer

Cross-reactivity data, based on available testing, is listed under the reactivity section of the datasheet. Contact us if you need reactivity confirmed for a species not listed.

Question 6

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

Anti-ST3GAL4 antibody

Product Specifications

CAS Number

Shipping Conditions

Storage Conditions

Shipping Temperature

Frequently Asked Questions

Explore Other Products

Anti-Mouse CD100/SEMA4D Antibody

Anti-Mouse CD100/SEMA4D Antibody

Anti-Mouse CD100/SEMA4D Antibody

Caspase 4 (CASP4) (NM_001225) Human Over-expression Lysate

MacroH2A Lentiviral Activation Particles (h)

CXCL9, CT (CXCL9, CMK, MIG, SCYB9, C-X-C motif chemokine 9, Gamma-interferon-induced monokine, Monokine induced by interferon-gamma, Small-inducible cytokine B9) (MaxLight 550) discontinued